Inflation Reduction Act Reforms Part 3: Federal Government Negotiation of Drug Prices

In this final part of the three-episode series on the Inflation Reduction Act, host Stephanie Dorvil and guest Joe Metro (Reed Smith, LLP) discuss the mechanics of the IRA’s federal drug price negotiation provisions. Under those provisions, the Department of Health and Human Services will identify a limited number of “selected drugs” each year and will negotiate a “maximum fair price” (MFP) for those drugs.

For more information, see Centers for Medicare & Medicaid Services (CMS) Inflation Reduction Act and Medicare.

• Part 1: Inflation Reduction Act Reforms - An Overview and Discussion of Inflation Rebates
• Part 2: Inflation Reduction Act Reforms - Changes to Part B and D Drug Benefit Design